Drug Profile


Alternative Names: Chloroquinoxaline sulfonamide; Chloroquinoxalone; CQS; NSC 339004

Latest Information Update: 06 Nov 2002

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator National Cancer Institute (USA)
  • Class Antineoplastics
  • Mechanism of Action Immunosuppressants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Cancer; Non-small cell lung cancer

Most Recent Events

  • 25 Sep 2000 No-Development-Reported for Non-small cell lung cancer in USA (IV)
  • 07 Oct 1997 Phase-II clinical trials for Non-small cell lung cancer in USA (IV)
  • 07 Oct 1997 A study has been added to the Cancer therapeutic trials and adverse events sections
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top